Phase 2 Readout~quarter

Phase 2 Readout: ampligen

Indication
pancreatic cancer

Other upcoming events for AIM

Phase 3 ReadoutPhase 3 Topline: Evaluation of Postoperative Recovery When Combining Intravenous Lidocaine With Ropivacaine Infiltrat

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: ampligen — AIM Phase 2 Readout | BioSniper